StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.89+0.07 (+3.85%)

Close on Nov 18, 2026Market cap $69.51MP/E –Yield –

Fortress Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Fortress Biotech's free cash flow for the twelve months ending Dec 31, 2024 was -$80.19M. For fiscal 2024 it was -$80.19M. The highest annual figure on record is -$10.95M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$80.19M–
FY2023Dec 31, 2023-$128.29M–
FY2022Dec 31, 2022-$182.12M–
FY2021Dec 31, 2021-$121.11M–
FY2020Dec 31, 2020-$85.61M–
FY2019Dec 31, 2019-$97.31M–
FY2018Dec 31, 2018-$105.93M–
FY2017Dec 31, 2017-$81.95M–
FY2016Dec 31, 2016-$52.18M–
FY2015Dec 31, 2015-$20.66M–
FY2014Dec 31, 2014-$16.33M–
FY2013Dec 31, 2013-$29.69M–
FY2012Dec 31, 2012-$23.25M–
FY2011Dec 31, 2011-$10.95M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$12.91M–
Q3 FY2024Sep 30, 2024-$18.66M–
Q4 FY2023Dec 31, 2023-$34.96M–
Q3 FY2023Sep 30, 2023-$16.78M–
Q2 FY2023Jun 30, 2023-$33.33M–
Q1 FY2023Mar 31, 2023-$43.22M–
Q4 FY2022Dec 31, 2022-$47.94M–
Q3 FY2022Sep 30, 2022-$44.25M–
Q2 FY2022Jun 30, 2022-$41.73M–
Q1 FY2022Mar 31, 2022-$48.20M–
Q4 FY2021Dec 31, 2021-$40.65M–
Q3 FY2021Sep 30, 2021-$22.16M–
Q2 FY2021Jun 30, 2021-$36.15M–
Q1 FY2021Mar 31, 2021-$22.15M–
Q4 FY2020Dec 31, 2020-$21.18M–
Q3 FY2020Sep 30, 2020-$23.37M–
Q2 FY2020Jun 30, 2020-$18.64M–
Q1 FY2020Mar 31, 2020-$22.42M–
Q4 FY2019Dec 31, 2019-$25.94M–
Q3 FY2019Sep 30, 2019-$16.76M–
Q2 FY2019Jun 30, 2019-$28.98M–
Q1 FY2019Mar 31, 2019-$25.63M–
Q4 FY2018Dec 31, 2018-$22.50M–
Q3 FY2018Sep 30, 2018-$26.89M–
Q2 FY2018Jun 30, 2018-$27.93M–
Q1 FY2018Mar 31, 2018-$28.61M–
Q4 FY2017Dec 31, 2017-$20.51M–
Q3 FY2017Sep 30, 2017-$25.63M–
Q2 FY2017Jun 30, 2017-$24.08M–
Q1 FY2017Mar 31, 2017-$11.74M–
Q4 FY2016Dec 31, 2016-$18.58M–
Q3 FY2016Sep 30, 2016-$10.28M–

More Fortress Biotech figures

See a number that looks wrong?